Spectral to Supply Reagents to Bio-Rad Pasteur | GenomeWeb

Spectral to Supply Reagents to Bio-Rad Pasteur

Nov 19, 2007

NEW YORK (GenomeWeb News) – Toronto-based Spectral Diagnostics said today it will provide Bio-Rad Pasteur with single chain Troponin I reagents under a license and supply agreement.

Spectral CEO Paul Walker said the “consistent revenue stream” from the agreement will generate capital the company needs to commercialize its FDA-approved endotoxemia assay, which also tests for the subsequent risk of sepsis.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Critics Say Open-Access Plan 'Goes Too Far'

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

Science and the Science Committee

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

And Gone

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

This Week in PLOS

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.